Indications and uses
Treatment against hyperpigmentation and age spots.
Treatment against hyperpigmentation and age spots.
Adults: Apply twice daily onto affected area after thorough cleansing or as directed by a doctor. Not recommended for use on children under 12 years of age. For children under age 12: ask a physician before use.
Hydroquinone 2%
Skin Lightener
Adults: Apply twice daily onto affected area after thorough cleansing or as directed by a doctor. Not recommended for use on children under 12 years of age. For children under age 12: ask a physician before use.
Treatment against hyperpigmentation and age spots.
Water, Caprylic/Capric Triglyceride, Glycerin, C12-15 Alkyl Benzoate, Cetyl Alcohol, Dimethicone, Glyceryl Stearate SE, Jojoba Esters, Polyglyceryl-3 Beeswax, Polyglyceryl-6 Distearate, Sodium Metabisulfite, Carbomer, Peg-4, Kojic Acid, Lactic Acid, Morus Alba Root Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Butylene Glycol, Arctostaphylos Uva-Ursi Leaf Extract, BHT, Sodium Hydroxide, Ginkgo Biloba Leaf Extract, Diospyros Kaki Fruit Extract, Betula Alba Bark Extract, Ruscus Aculeatus Root Extract, Hydrolyzed Soy Protein, Arbutin, Thioctic Acid, Ubiquinone, Retinol, Polysorbate 20, BHA, Ascorbic Acid (Vitamin C), Retinyl Palmitate (Vitamin A), Tocopheryl Acetate (Vitamin E), Benzyl Alcohol, Fragrance, Dehydroacetic Acid
Keep out of reach of children.
Pharmaskincare BrighteningParfaitSerum.jpg
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68062-9104 | 68062-9104-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | IACT |
| WATER | 059QF0KO0R | IACT |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| HYDROQUINONE | XV74C1N1AE | ACTIB |
| ALKYL (C12-15) BENZOATE | A9EJ3J61HQ | IACT |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| de33b10a-c879-caa4-e053-2995a90a1d7f | 5b4ecd81-15bc-28b3-e053-2991aa0adc9c | 2022-05-04 | Warnings | 5b4ecd81-15bc-28b3-e053-2991aa0adc9c |
Adverse event summaries are temporarily unavailable. Other product information remains available.